Pfizer asks FDA to authorize booster for kids 5-11

Pfizer and BioNTech submitted an emergency use authorization request to the FDA on April 26 for a COVID-19 vaccine booster for children ages 5-11. 

Advertisement

The application included positive clinical trial results from children who received a booster about six months after their second dose of Pfizer’s vaccine. The shot received emergency use authorization for this age group in October 2021. 

At present, boosters are cleared only for people 12 and older. 

Pfizer and Moderna are also slated to submit applications for their COVID-19 shots for kids younger than 5 this spring. 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.